OncoDaily
banner
oncodaily.bsky.social
OncoDaily
@oncodaily.bsky.social
Your daily dose of hope, inspiration, and information in the fight against cancer.
oncodaily.com
MiNK Therapeutics Reports Durable Responses with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

oncodaily.com/trial-update...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MiNK
MiNK Therapeutics Reports Durable Responses with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025 - OncoDaily
MiNK Therapeutics Reports Durable Responses with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025 / agenT-797, biotech,
oncodaily.com
November 9, 2025 at 9:11 PM
Global Trends in Pancreatic Cancer, 2010–2021: Incidence, Mortality, and DALYs from the Global Burden of Disease Study

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Global Trends in Pancreatic Cancer from 2010 to 2021
A global analysis of 2010–2021 data shows a rising pancreatic cancer burden, especially in females and low-SDI countries.
oncodaily.com
November 9, 2025 at 9:11 PM
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Daratumumab #MM #Myeloma
November 9, 2025 at 9:10 PM